fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Mutual Funds » UTI Healthcare Fund

UTI Healthcare Fund - G

NAV  ₹273.711 ↑ 1.51  (0.56 %) as on 19 May 25

(Erstwhile UTI Pharma & Healthcare Fund)

Scheme Objective

The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors.

UTI Healthcare Fund is a Equity - Sectoral fund launched on 28 Jun 99. It is a fund with High risk and has given a CAGR return of 14.9% since its launch.  Ranked 40 in Sectoral category.  Return for 2024 was 42.9% , 2023 was 38.2% and 2022 was -12.3% .

Below is the key information for UTI Healthcare Fund

NAV as on 19 May 25₹273.711 ↑ 1.51  (0.56 %)
Net Assets (AUM) as on 30 Apr 2025 ₹1,037 Cr.
Launch Date28 Jun 1999
CategoryEquity - Sectoral
Rating
TypeOpen Ended Fund
RiskHigh
AMCUTI Asset Management Company Ltd
Alpha Ratio0.57
Expense Ratio2.38 %
Sharpe Ratio0.688
Information Ratio-0.24
BenchmarkNot Available
Min Investment ₹5,000
Min SIP Investment ₹500
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Returns

Annual Compounded Returns

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 19 May 25

DurationReturns
1 Month 2.2%
3 Month 5.9%
6 Month -1.6%
1 Year 21.6%
3 Year 24.1%
5 Year 22.8%
10 Year
15 Year
Since launch 14.9%

Historical Annual Returns

Historical performance (Yearly) on absolute basis

YearReturns
2024 42.9%
2023 38.2%
2022 -12.3%
2021 19.1%
2020 67.4%
2019 1.2%
2018 -7.5%
2017 6.2%
2016 -9.7%

Growth of 10k Over Years

DateValue
30 Apr 20₹10,000
30 Apr 21₹15,214
30 Apr 22₹15,571
30 Apr 23₹15,015
30 Apr 24₹22,423
30 Apr 25₹27,036

Asset Allocation

Asset ClassValue
Cash1.08%
Equity98.92%

Sector Allocation

SectorValue
Health Care97.95%
Basic Materials0.97%

Top Securities Holdings / Portfolio

Holdings/Securities

NameGlobal IndustryHoldingValueQuantity
Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA
Drug Manufacturers - Specialty & Generic12%₹123 Cr672,889
↓ -27,111
Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | 500087
Drug Manufacturers - Specialty & Generic6%₹62 Cr400,000
↓ -20,000
Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | DRREDDY
Drug Manufacturers - Specialty & Generic5%₹47 Cr396,000
Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | 532331
Drug Manufacturers - Specialty & Generic5%₹47 Cr172,829
↓ -2,056
Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Dec 20 | PGHL
Drug Manufacturers - Specialty & Generic4%₹41 Cr79,763
↑ 5,763
Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 21 | APOLLOHOSP
Medical Care Facilities4%₹39 Cr56,271
Glenmark Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 24 | 532296
Drug Manufacturers - Specialty & Generic4%₹38 Cr275,250
Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB
Drug Manufacturers - Specialty & Generic3%₹34 Cr56,000
Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 May 21 | ALKEM
Drug Manufacturers - Specialty & Generic3%₹33 Cr63,840
Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Dec 20 | 532843
Medical Care Facilities3%₹32 Cr465,000
1 - 10 of 45
Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Fund Managers

NameSinceTenure
Kamal Gada2 May 223 Yr.

Custodians

CompanyAddress
Axis Bank Ltdnull
Deutsche Bank AG MUMBAIDeitsche bank,Kodak House
Stock Holding Corporation of IndiaMittal Court, ‘B’ Wing,,Nariman Point

Registrar & Transfer Agent

KFin Technologies Ltd
Address138 -Suyesh Solitaire, Nr. Podar International School,Kudasan, Gandhinagar, Gujarat
FAXN.A
EmailN.A

Administrator Companies

CompanyAddress
UTI Asset Management Co LtdPMS Division, UTI - Tower, “Gn” Block, Bandra Kurla Complex, Mumbai- 400051

Auditors

CompanyAddress
S. R. BATLIBOI & CoExpress Tower, 6th Floor,Nariman Point,Mumbai

All Plan & Options

Fund and PlanNAV6 Month1 Year3 Year5 Year
UTI Healthcare Fund
Growth
₹273.711
↑ 1.51
-1.63 %21.55 %24.13 %22.82 %
UTI Healthcare Fund
Normal Dividend, Payout
₹211.54
↑ 1.17
-1.63 %21.55 %24.13 %22.82 %
UTI Healthcare Fund
Normal Dividend, Reinvestment
₹211.54
↑ 1.17
-1.63 %21.55 %24.13 %22.82 %
Data as on 19 May 25

Disclaimer:
All efforts have been made to ensure the information provided here is accurate. However, no guarantees are made regarding correctness of data.